Profil
Lyndsey Scull worked as a Director of Corporate Communications at Magenta Therapeutics, Inc. from 2019 to 2021.
Anciens postes connus de Lyndsey Scull
| Sociétés | Poste | Fin |
|---|---|---|
| MAGENTA THERAPEUTICS | Investor Relations Contact | 01/10/2021 |
Expériences
Fonctions occupées
Relations
17
Relations au 1er degré
1
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |